Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions

Postoperative pancreatic fistula is the most important complication after laparoscopic distal pancreatectomy for tumors of the body and tail of the pancreas. It can cause infection, bleeding, longer hospital stay, and even death. New imaging technology using indocyanine green (ICG) dye and near-infrared fluorescence may help surgeons see blood flow to the pancreatic stump, spleen, and nearby vessels during surgery and make safer decisions about where to cut and which structures to preserve. This study will compare two standard laparoscopic operations for pancreatic body and tail lesions: one

Trial Details

NCT ID
NCT07656571
Phase
NA
Sponsor
Alexandria University
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • ICG Fluorescence-Guided Laparoscopic Distal Pancreatectomy
  • Standard Laparoscopic Distal Pancreatectomy
Locations (sample)
  • Alexandria, Egypt|31.20176,29.91582

Key Eligibility Criteria

  • Age ≥ 18 years.
  • Body mass index (BMI) ≤ 40 kg/m².
  • Radiologically confirmed lesion(s) of the pancreatic body and/or tail requiring elective distal pancreatectomy, with or without splenectomy.
  • Lesion amenable to a laparoscopic approach as determined by the operating surgeon on preoperative CT or MRI imaging.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →